Experienced in Rheumatoid Vasculitis

Hubert Marotte

Saint-etienne-de-valoux, FR 
Experienced in Rheumatoid Vasculitis
Saint-etienne-de-valoux, FR 
OverviewLocationsClinical Research

Overview

Hubert Marotte practices in Saint-etienne-de-valoux, France. Mr. Marotte is rated as an Experienced expert by MediFind in the treatment of Rheumatoid Vasculitis. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Rheumatic Fever, Liver Embolization, and Vertebroplasty.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Rheumatoid Vasculitis.

Gender
Male

Locations

Saint-etienne-de-valoux, 42055, France
Other Locations
Saint-jean-saint-germain, 42023, France
Auvergny, 42023, France
Toulouse, France
Lyon, 42055, France
Saint-priest-la-vetre, France
Université St Etienne
Paris, France
U1059-INSERM, Université Jean Monnet St Etienne, Saint-etienne, France
Saint Étienne, France
4 Rue Larrey, 49933 Angers Cedex 9, Angers, 49933, France
avenue Albert Raimond
Albert, 42055, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Biological, Diagnostic test
Study Drug: Blood sample
Study Phase: Phase 4
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 18, 2024
Intervention Type: Drug, Biological
Study Drugs: Secukinumab, TNF blocker, Blood specimen
Study Phase: Phase 4
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Enrollment Status: Completed
Publish Date: July 16, 2024
Intervention Type: Drug
Study Drugs: NSAIDs, anti-TNF
Study Phase: Phase 3
Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Enrollment Status: Terminated
Publish Date: February 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Device
Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients
Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Biological, Behavioral
Study Phase: Not Applicable
Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA)
Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA)
Enrollment Status: Withdrawn
Publish Date: May 03, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Not Applicable
Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study
Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study
Enrollment Status: Completed
Publish Date: March 17, 2021
Intervention Type: Drug
Study Phase: Not Applicable
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Biological, Diagnostic test
Study Phase: Phase 4
Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis
Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
Enrollment Status: Terminated
Publish Date: July 24, 2020
Intervention Type: Other
Role of the Sympathetic Nervous System (ANS) Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF (Tumor Necrosis Factor) - a Monocentric Cross-sectional Study
Role of the Sympathetic Nervous System (ANS) Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF (Tumor Necrosis Factor) - a Monocentric Cross-sectional Study
Enrollment Status: Completed
Publish Date: June 26, 2019
Intervention Type: Device
Study Phase: Not Applicable
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
Enrollment Status: Completed
Publish Date: October 29, 2018
Intervention Type: Device
Study Phase: Not Applicable
Monocentric Study Evaluating Bone Microarchitecture by High Resolution Quantitative Computerized Tomography (HR-pQCT) in Young Adults and Adolescents Who Developed Anorexia Nervosa (AN) in Peri or Prepubertal Period.
Monocentric Study Evaluating Bone Microarchitecture by High Resolution Quantitative Computerized Tomography (HR-pQCT) in Young Adults and Adolescents Who Developed Anorexia Nervosa (AN) in Peri or Prepubertal Period.
Enrollment Status: Completed
Publish Date: February 22, 2018
Intervention Type: Device, Other
Study Phase: Not Applicable
View 13 Less Clinical Trials

126 Total Publications

Early upper and lower limbs bone microarchitecture alterations evaluated by HR-PQCT after stroke with hemiplegia.
Early upper and lower limbs bone microarchitecture alterations evaluated by HR-PQCT after stroke with hemiplegia.
Journal: Joint bone spine
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Marotte's expertise for a condition
ConditionClose
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile